Select Page
Discussion on the importance of autopsies and biopsies in confirming vaccine-induced myocarditis.
  • Focus on silent vaccine-induced myocarditis confirmed by biopsies. 0:04

  • Continued education and sharing of information on autoimmunity in COVID-19 since March 2020. 0:48

  • Intramyocardial inflammation confirmed through Endomyocardial biopsy in patients. 1:31

  • Study conducted in Germany with funding from the European Regional Development Fund. 1:31

  • Myocarditis is defined as inflammation of the heart. 1:52

  • No conflicts of interest reported in the study. 2:11

  • Emphasis on the need for autopsies to provide histopathological evidence of the pandemic. 2:33

Study confirms vaccine-induced myocarditis in patients through biopsy and echocardiogram findings.
  • 93% of cases confirmed to have vaccine-induced myocarditi. 2:59

  • Study conducted on 15 cases with symptoms of myocarditi. 2:59

  • Patients received various vaccines including Johnson & Johnson, AstraZeneca, and Pfize. 4:02

  • Age range of patients from 18 to 68 years ol. 4:24

  • Echocardiogram used to determine left ventricular ejection fractio. 5:09

  • Left ventricular ejection fraction consistently below normal range in all patient. 5:09

Illustration of echocardiogram process, normal heart function, and a case study of a 38-year-old woman with heart condition.
  • Echocardiogram process involves placing a probe on the chest with jelly to view the heart’s pumping and valves. 5:52

  • A normal heart has ventricles and atria that pump blood around the body, with left ventricular ejection fraction measuring blood pushed out. 6:49

  • Abnormal heart function can result in a poor left ventricular ejection fraction, leading to inefficient blood pumping. 7:31

  • A specific case study of a 38-year-old woman with a heart condition is presented as case number 10. 7:51

Significant myocarditis induced by vaccine in asymptomatic patient with low ejection fraction.
  • 38-year-old female with 40% ejection fraction post-vaccin. 8:13

  • Patient classified as New York Heart Association class one with no symptom. 8:40

  • Normal troponin, BNP, CK, and CRP levels despite myocarditi. 9:21

  • Importance of monitoring asymptomatic patients for myocarditis post-vaccinatio. 10:10

  • Need for better identification and management of silent myocarditis case. 10:34

Importance of conducting autopsies and biopsies to assess risks of interventions.
  • Shift in vaccination focus from high-risk cohort should have been carefully evaluated. 11:19

  • Severe COVID-19 patients had comorbidities, making them the initial target group for vaccination. 11:47

  • Delay in reevaluating vaccination strategy for younger age groups may pose risks. 12:10

  • Emphasizes the importance of conducting autopsies and biopsies for informed decision-making. 12:35

  • Minor symptoms should not be disregarded; thorough investigation is crucial. 12:58